Please Wait.....
Report
Europe Biopsy Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 90 Pages I Mordor Intelligence
Europe Biopsy Devices Market Analysis
The Europe biopsy devices market size stood at USD 623.89 million in 2025 and is forecast to reach USD 763.44 million by 2030, advancing at a 4.12% CAGR. Demand continues to rise as organized cancer-screening programs expand, hospitals upgrade to EU Medical Device Regulation (MDR)-compliant equipment, and physicians shift toward imaging-guided, minimally-invasive techniques. Adoption of vacuum-assisted and core needle systems is accelerating because they reduce sampling errors, shorten procedure time, and integrate easily with MRI or CT guidance. Conversely, supply bottlenecks linked to MDR certification delays keep pricing firm and create procurement gaps, especially for smaller facilities. Safety-related product recalls underscore the need for robust post-market surveillance, prompting hospitals to favor vendors that can demonstrate strong quality systems. Across the region, national reimbursement reforms are steering a growing share of biopsies to ambulatory surgical centers, lowering overall procedure costs while preserving hospital capacity for complex oncology cases.
Europe Biopsy Devices Market Trends and Insights
Increasing Preference for Minimally-Invasive Procedures
Transperineal prostate biopsies now represent standard-of-care across leading urology centers after a multicenter trial showed lower infection rates than the traditional transrectal route, without compromising diagnostic accuracy. MRI-guided freehand techniques for small liver lesions reach 90% clinical success, encouraging their dissemination to oncology units that previously relied on CT guidance. Such patient-friendly modalities shorten recovery time and reduce hospital stays, aligning with payer cost-containment goals. Research groups are now testing nanoneedle patches capable of sampling intracellular biomarkers painlessly, a breakthrough that could reach clinical practice by 2026. These advances should keep the Europe biopsy devices market on a steady adoption curve even as regulatory hurdles rise.
Rising Cancer Screening Programs Across EU-27
The European Commission's Beating Cancer Plan earmarked EUR 4 billion to achieve 90% screening coverage for breast, cervical, and colorectal cancers by 2025, and has broadened scope to lung and prostate cancers. Organized programs replace opportunistic screening, compelling health systems to buy standardized biopsy kits, training mannequins, and AI-enabled image-review software. Updated mortality projections for 2025 already show a 9.8% decline in breast-cancer deaths among women aged 50-69, a result that is reinforcing political support for national screening budgets. Central and Eastern European countries, historically under-equipped, are channeling EU cohesion funds into mobile biopsy units to close access gaps. This policy-driven demand supports a predictable, multi-year order pipeline for device suppliers.
Product Recalls & Safety Notices
Hologic voluntarily withdrew more than 91,000 BioZorb 3D markers after 188 adverse-event reports of pain, infection, and migration, triggering a Class I recall and heightening regulatory scrutiny. The FDA also flagged Stereotactic disposable needle kits that risked stainless-steel debris contamination, prompting EU vigilance notices and procurement freezes. Hospitals now impose stricter supplier audits and require real-time batch traceability, lengthening sales cycles and raising support costs for manufacturers. These episodes dampen near-term volume growth within the Europe biopsy devices market but reinforce the strategic value of robust quality-management systems.
Other drivers and restraints analyzed in the detailed report include:
Shift Toward Ambulatory & Outpatient Biopsy Centers / EU In-Vitro Diagnostic Regulation Driving Device Upgrades / Stringent MDR Certification Timelines Causing Supply Gaps /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Needle-based systems dominated the Europe biopsy devices market with a 48.25% revenue share in 2024, and they will grow at an 8.35% CAGR toward 2030 as physicians upgrade to core and vacuum-assisted platforms that minimize sampling errors. Core devices now feature sharper tip designs, proprietary coatings, and adjustable throw lengths that preserve tissue architecture for genomic assays. Vacuum-assisted handpieces collect multiple contiguous cores through a single incision, reducing repeat procedures; the VACIS trial even positions vacuum excision as a surgery-sparing option for low-grade ductal carcinoma in situ. Steady demand also persists for localization wires and radioactive seed systems that guide breast-conserving surgery, although adoption varies with reimbursement. Digital guidance consoles integrate electromagnetic tracking with real-time ultrasound, easing workflow in busy ambulatory centers. NeoDynamics' pulse-technology device underscores continuing innovation aimed at shortening procedure time and operator learning curves.
Procedure trays, markers, and ancillary kits deliver recurring consumable sales that insulate vendors from capital-budget cycles. Price competition remains moderate because MDR compliance costs limit new entrants. Hospitals prioritize suppliers that offer comprehensive portfolios-core needles, vacuum systems, localization tools, and AI-ready consoles-along with field-service capabilities that ensure uninterrupted screening workflows.
The Europe Biopsy Devices Market Report is Segmented by Product (Needle-Based Biopsy Instruments [Core Biopsy Devices, and More], Procedure Trays, and More), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, and More), End User (Hospitals, Diagnostic & Imaging Centers, and More), and Geography (Germany, United Kingdom, France, Italy, Spain, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Beckton Dickinson / Hologic / Devicor Medical Products / Cook Group / Boston Scientific / Intact Medical / Gallini Medical / TSK Laboratory Europe / Argon Medical Devices / Medtronic / Olympus / Cardinal Health / Danaher / Stryker / IZI Medical Products / FUJIFILM / Merit Medical Systems /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference For Minimally-Invasive Procedures
4.2.2 Rising Cancer Screening Programs Across EU-27
4.2.3 Shift Toward Ambulatory & Outpatient Biopsy Centers
4.2.4 Technological Convergence Of Imaging-Guided Robotics
4.2.5 EU In-Vitro Diagnostic Regulation Driving Device Upgrades
4.3 Market Restraints
4.3.1 Product Recalls & Safety Notices
4.3.2 Stringent MDR Certification Timelines Causing Supply Gaps
4.3.3 Limited Reimbursement For Novel Vacuum-Assisted Systems
4.4 Regulatory Landscape
4.5 Technological Outlook
4.6 Porter's Five Forces
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product
5.1.1 Needle-based Biopsy Instruments
5.1.1.1 Core Biopsy Devices
5.1.1.2 Aspiration Biopsy Needles
5.1.1.3 Vacuum-assisted Biopsy Devices
5.1.2 Procedure Trays
5.1.3 Localization Wires
5.1.4 Other Products
5.2 By Application
5.2.1 Breast Biopsy
5.2.2 Lung Biopsy
5.2.3 Colorectal Biopsy
5.2.4 Prostate Biopsy
5.2.5 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Diagnostic & Imaging Centers
5.3.3 Ambulatory Surgical Centers
5.3.4 Others
5.4 Geography
5.4.1 Germany
5.4.2 United Kingdom
5.4.3 France
5.4.4 Italy
5.4.5 Spain
5.4.6 Rest of Europe
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
6.3.1 Becton, Dickinson and Company
6.3.2 Hologic Inc.
6.3.3 Devicor Medical Products Inc.
6.3.4 Cook Medical
6.3.5 Boston Scientific Corporation
6.3.6 Intact Medical Corporation
6.3.7 Gallini Medical
6.3.8 TSK Laboratory Europe BV
6.3.9 Argon Medical Devices
6.3.10 Medtronic plc
6.3.11 Olympus Corporation
6.3.12 Cardinal Health
6.3.13 Danaher Corporation
6.3.14 Stryker Corporation
6.3.15 IZI Medical Products
6.3.16 FUJIFILM Holdings Corporation
6.3.17 Merit Medical Systems
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security